Search Results Page

Pfizer is a bright spot

about 11 years ago

In an otherwise lackluster market, Pfizer is a bright spot, thanks to its exuberant Q2 performance. The stock which had closed yesterday at Rs.2438.55, hit an intra day high at Rs.2600. Volumes are pretty robust at around 3 lakh shares compared to 11,000 shares on a two-week average. Pfizer ...

Pfizer in the spotlight

about 10 years ago

Pfizer is most obviously the newsmaker today. It announced yesterday after market closure that it has entered into an Acquisition Agreement with AstraZeneca AB, Sweden ('AstraZeneca'), pursuant to which the brand 'Neksium' is being acquired

Pfizer hits a new high

about 7 years ago

The stock has been among the top three gainers on the BSE, going on to hit a new 52-week high at Rs.4929.85

Pfizer gets a shot!

about 6 years ago

This news was enough for the stock, which rose 19.5% to Rs.5875, hitting a new high, close to its 20% UC of the day at Rs.5901.40.

Pfizer in the limelight

about 12 years ago

Pfizer is a big gainer on the bourses in the morning trade. The stock, currently up almost 4.5% at Rs.2045 had gone up to an intra day high of Rs.2081.95. Volumes are up over 2 times and its 52-week high is at Rs.2325. The stock is in the limelight today after its US based parent announced t ...

Pfizer suffers side effects

about 11 years ago

On 10th March, India banned the manufacture and sale of more than 300 combination medicines, including two widely used cough syrups, being sold without government approval. Reuters has reported that though combination drugs are used worldwide to improve patients' compliance, in India the ...

Pfizer gets a boost

about 6 years ago

Today, it opened 7% higher at Rs.4245 and went on to an intraday high at Rs.4313.40, rising over 8.5%.

Pfizer in the news

about 2 years ago

The stock rose to an intraday high at Rs.4448.35, up almost 9%. The stock is closer to its 52- low of Rs.4012.65 rather than the high of Rs.6452.85.

Pfizer: A bitter pill

about 12 years ago

Shares of Pfizer Ltd. are down Rs. 53 or little over 3%, and currently trading at Rs. 1,653 a piece. The second quarter financial performance was poor, which resulted in poor reaction by the market. Revenue in the second quarter dropped 11% QoQ to Rs. 296 crore, while fall in bottomline was ...

Bliss GVS Pharma gets paralyzed

about 13 years ago

Bliss GVS Pharma, which was buzzing in trade last week on rumours of stake sale to Pfizer and had touched a high of 41.30, seems to be under malaria attack! The Mumbai based female contraceptive, soft pessaries and suppositories maker, is down close to 3.6% at Rs. 34.90, after Ghana FDA black-lis ...

Bliss GVS Pharma gets a 'side effect'

about 13 years ago

Bliss GVS Pharma, Mumbai based female contraceptive maker, is down close to 13% at Rs. 33.30, after the company denied its management being in talks with Pfizer to sell a unit or stake in the company. Company has categorically denied running a sale mandate based on the rumours floating on social ...

WYETH's UPCOMING AMALGAMATION WITH PFIZER: Shareholder of which company gains?

about 13 years ago

Swap ratio is likely to be in the range of 1.8:1 to 2.2:1, with former benefiting Wyeth shareholders while latter better for Pfizer shareholders. Company has the carrot (and a real big one) of interim dividend to pacify either of the shareholders.

VACCINE - BOOSTER SHOT FOR HOPE AND MARKETS!

about 6 years ago

The win of Biden does not really change the lives of majority of us Indians but the news that a vaccine has finally been invented is the only news we all have been waiting to hear. And yesterday, Pfizer announced that news saying that it’s vaccine, in collaboration with German company, BioNTech SE prevented more than 90% of infections in a study of over 40,000 volunteers.

INDIA’S COVAXIN – SHOT IN THE DARK?

about 6 years ago

Nothing would be better than taking a vaccine for the dreaded Covid by a product manufactured in India. But at this juncture, even if the product was available, most of us would be wary and if given an option, if there is ample supply available, Pfizer would be the most preferred vaccine.

VACCINATE LIKE WE DO ELECTIONS!

about 6 years ago

Apart from the challenges of the cold-storage which the Pfizer vaccine elaborated, the big question in everyone’s mind is how will India distribute? Are we logistically, capable enough? The answer is a vehement “YES!” We are more than capable but what the Govt needs to show is the will to get this right.

Corona Remedies

about 10 months ago

All for Growth
Subscription Start Date :8 Dec 2025 End Date :10 Dec 2025
Issue Size : Rs. 655 cr, Issue Type : OFS
Price Band : Rs.1008 to Rs. 1062
--------------------------------------------------
Overall Subscription : 137x
QIB : 208.9x,HNI :278.5x,Retail :28.7x
Listing Date : 15 Dec 2025, , Listing Price : 1470

GATES – OPPORTUNIST IN GARB OF PHILANTHROPIST?

about 6 years ago

Bill Gates? Putting corporate profitability and capitalism ahead of human lives? Is this the same man who waxed eloquent about how he has helped bring malaria to the fore and getting it on the world stage, helping save lives? Is he the man who has, till now, enjoyed this image of being a white rich man who wants to help and save the poor, the completely downtrodden, in the under-developed and developing world?

BUFFETT BACK IN BUYING MODE!

about 6 years ago

More than the stock market being the barometer of the economy, it is Warren Buffett whose buying or selling indicates where the needle of the economy is headed. Buffett said that he has always been a net buyer since the age of 11, when he started his journey in the market. That’s why panic buttons were jammed up when in September he sold instead of buying when the markets crashed.

Astrazeneca Pharma in the red

about 10 years ago

Astrazeneca Pharma is deep in the red today, with the stock going down over 6% at Rs.1072 with an intra day low at Rs.1050. The stock is down in the red, reacting to its announcement which came in yesterday. The company stated that AstraZeneca UK has terminated distribution arrangements with ...

Aurobindo gets dose from SEBI

about 7 years ago

Aurobindo Pharma opened weaker at Rs.601 v/s yesterday’s close of Rs.613.80, going down further to an intra day low at Rs.589.50.

Snowman Logistics goes "Brrrrr"

about 6 years ago

The stock rose over 15% to hit an intraday high at Rs.41, not too far from its 20% UC of the day at Rs.42.70. Its 52-week high is at Rs.45.80.